Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation.
De Luca G, Michael Gibson C, Bellandi F, Murphy S, Maioli M, Noc M, Zeymer U, Dudek D, Arntz HR, Zorman S, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Huber K, Van't Hof AW.
De Luca G, et al. Among authors: dudek d.
J Thromb Thrombolysis. 2009 Oct;28(3):288-98. doi: 10.1007/s11239-008-0296-9. Epub 2008 Nov 22.
J Thromb Thrombolysis. 2009.
PMID: 19030969